SNEX StoneX Group Inc. Insider Trading

Maurer Mark Lowry sold 11,398 shares of SNEX at $112.25 on 2026-05-22 for $1,279,374.21; continues pattern of well-timed exits.

Maurer Mark Lowry executed a sale of 11,398 shares at $112.25, reducing holdings by 7.8% to 135,496 shares. His cross-ticker track record shows 2 prior sells with a 90-day well-timed rate of 100.00%, and at SNEX specifically, his prior 2 sales (on 2026-05-14 and 2026-02-09) both exhibited negative 90-day returns, meaning the stock declined after he sold. The current sale occurs at $112.25 while the stock currently trades at $113.91, with the stock up 33.4% over 90 days and near its 52-week high of $125.42. The timing of this exit—following a sharp 90-day rally and preceding the year's recent highs—is consistent with his historical pattern of selling into strength at SNEX, where 2 of 2 prior trades showed the stock moving lower in the 90 days following his sales. This recurring pattern warrants observation of post-sale price action.

CEO Philip Andrew Smith sells 8,535 SNEX shares at $112.72; 10b5-1 plan execution, -1.7% of holdings.

Philip Andrew Smith, Chief Executive Officer of StoneX Group Inc., sold 8,535 shares at $112.72 on 2026-05-22, reducing his holdings to 506,184 shares. This transaction is part of a pre-arranged 10b5-1 trading plan, meaning it was scheduled rather than discretionary. His prior sales at this ticker show mixed outcomes: the most recent sale on 2026-04-10 saw +32.2% 30-day returns, while earlier 2025 sales resulted in negative returns ranging from -11.0% to -40.1% over 30 days. The CEO retains substantial holdings at 506,184 shares post-transaction, and the company fundamentals remain solid with annual revenue growth of +16.2% and a P/E of 19.54.

StoneX Chief Governance/Legal Officer Rotsztain sells 33,750 shares for $3.8M via pre-arranged 10b5-1 plan

Rotsztain executed 2 separate sales totaling 33,750 shares for $3,780,411.91 at blended average price $112.01, reducing his holdings by 59.2% from 56,997 shares to 23,247 shares post-transaction. The sales occurred on 2026-05-18 and 2026-05-20 under a pre-arranged 10b5-1 trading plan, meaning the sales were scheduled rather than discretionary. StoneX fundamentals show strong quarterly revenue of $829,100,000.00, net income of $174,300,000.00, and 16.2% annual revenue growth, with the stock currently trading at $109.37, down 12.8% from its 52-week high of $125.42. Since these sales are program-driven under a 10b5-1 plan, they carry no timing signal about the insider's contemporaneous view of valuation or near-term prospects.

Executive Vice-Chairman Sean Michael Oconnor sells 300,000 SNEX shares for $33.2M via 10b5-1 plan

Sean Michael Oconnor, who was Executive Vice-Chairman, executed 3 separate sales totaling 300,000 shares for $33,166,803.15 at an average price of $110.56 on May 15, 18, and 19, 2026. This represents a -19.5% reduction in his holdings from 1,536,921 to 1,236,921 shares. The sales occurred under a pre-arranged 10b5-1 trading plan, meaning execution was scheduled rather than discretionary. His prior 5 sales at SNEX showed average 30-day returns of -43.7% to -57.8%, with 90-day returns ranging from -47.0% to -2.2%, establishing a pattern of stock weakness following his sales at this specific ticker. The current price of $109.37 sits -12.8% from the 52-week high of $125.42, suggesting the stock remains near elevated levels relative to recent history.

CFO William J Dunaway sold 64,017 shares of SNEX for $7.1M via scheduled 10b5-1 plan

William J Dunaway, Chief Financial Officer of StoneX Group Inc., sold 64,017 shares at $110.46 under a pre-arranged 10b5-1 trading plan on 2026-05-15, reducing his holdings from 337,603 shares to 273,586 shares (a -19.0% reduction in position size). The sale occurred at a price that sits -11.7% below the 52-week high of $125.42, amid a company showing solid near-term momentum (+4.5% over 30 days and +31.4% over 90 days). SNEX reports strong fundamentals with $829.1M in latest quarterly revenue, $174.3M net income, and +16.2% annual revenue growth. Since this transaction is scheduled under a 10b5-1 plan rather than a discretionary trade, the timing does not reflect market judgment. The CFO retains a substantial stake of 273,586 shares post-sale, maintaining material economic exposure to the company's performance.

Maurer Mark Lowry sold 34,862 shares at $116.29 on 2026-05-14 via scheduled 10b5-1 plan; holding reduced to 146.9K shares.

Mark Lowry executed 2 separate sales totaling 34,862 shares for $4,054,248.40 on 2026-05-14 under a pre-arranged 10b5-1 trading plan, reducing his stake by 19.2% to 146,894 shares. The 10b5-1 flag indicates this was a scheduled, non-discretionary transaction, so no timing signal can be inferred from the sale itself. Fundamentals are solid: StoneX reported $829.1M quarterly revenue, $174.3M net income, and 16.2% annual revenue growth, with a P/E of 18.90. The stock has climbed 29.7% over 90 days and trades at $110.21, slightly below its 52-week high of $125.42, providing context for a large planned liquidation by this insider.